Business Journal Florida: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Journal Florida.

Press releases published on November 3, 2026

Nov. 3, 2026

A Futurionex integrou uma nova entidade com licença de FSP autorizada pela FSCA da África do Sul, aprimorando ainda mais a sua estrutura de conformidade global.

Indeterminate GlobeNewswire

Nov. 3, 2026

Futurionex Adds South Africa FSCA-Authorized FSP Licensed Entity, Further Strengthening Global Compliance

Indeterminate GlobeNewswire

Nov. 3, 2026

Decoy Therapeutics Provides Third Quarter 2026 Business Update

Indeterminate GlobeNewswire

Nov. 3, 2026

Hydrofarm Eliminates $109 Million in Debt, Becoming Debt-Free

Indeterminate GlobeNewswire

Nov. 3, 2026

Kailera Therapeutics to Participate in November Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Nexera Technologies: Subsidiary Fort Technology Announces Receipt of Approval for a Voluntary Delisting of its Common Shares From the TSX Venture Exchange

Indeterminate GlobeNewswire

Nov. 3, 2026

Renee Mustered Announces a New Milestone in Vilomah’s Development as a Grief-Support Platform

Indeterminate GlobeNewswire

Nov. 3, 2026

Nearly one-third of the world’s largest companies have not publicly acknowledged any AI risks

Indeterminate GlobeNewswire

Nov. 3, 2026

Xometry Reports Record Third Quarter 2026 Results

Indeterminate GlobeNewswire

Nov. 3, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 3, 2026

Viirtue Moves Into New Downtown St. Petersburg Office at 360 Central Avenue

Indeterminate EIN Presswire

Nov. 3, 2026

UPDATE: Accelerated Wealth Partners Enters into Definitive Agreement to Partner with $5 Billion Wealth Manager Pallas Capital Advisors

Indeterminate GlobeNewswire

Nov. 3, 2026

MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer

Indeterminate GlobeNewswire

Nov. 3, 2026

Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities

Indeterminate GlobeNewswire

Nov. 3, 2026

Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO®, AJOVY® and UZEDY®; Delivers Substantial Gross Margin Expansion

Indeterminate GlobeNewswire

Nov. 3, 2026

Cardiff Oncology to Participate in the UBS Global Biopharma Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Maze Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

ZENOTTIC Unveils New Global Brand Direction With “A Pair for Every You”

Indeterminate GlobeNewswire

Nov. 3, 2026

Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

Indeterminate GlobeNewswire